Latest Articles

Publication Date
All News Scientific
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal

Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal

Published: Nov. 13, 2025, 1:03 p.m.
Read Full Article
Rollout of clinics to treat endometriosis - The Australian

Rollout of clinics to treat endometriosis The Australian

Published: Nov. 13, 2025, 1:01 p.m.
Read Full Article
Unheard. Unserved: After Costly U.s. Surgery, Endometriosis Patient Pushes For More Options - beritaja.com

Unheard. Unserved: After Costly U.s. Surgery, Endometriosis Patient Pushes For More Options beritaja.com

Published: Nov. 13, 2025, 11:09 a.m.
Read Full Article
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - unpublished.ca

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options unpublished.ca

Published: Nov. 13, 2025, 11:05 a.m.
Read Full Article
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Unpublished Media

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Unpublished Media

Published: Nov. 13, 2025, 11:05 a.m.
Read Full Article
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Global News

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Global News

Published: Nov. 13, 2025, 11 a.m.
Read Full Article
MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon - Слободен печат

MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon Слободен печат

Published: Nov. 13, 2025, 10:57 a.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.
Read Full Article
Interventions for endometriosis-related pain and infertility: a protocol for systematic review and network meta-analysis.

Endometriosis, a chronic oestrogen-dependent disorder, presents significant clinical challenges including pelvic pain, dysmenorrhoea, dyspareunia and infertility. While numerous interventions exist, evidence guiding the choice among surgical, hormonal and non-hormonal therapies …

Published: Nov. 13, 2025, midnight
Read Full Article
GYNAECOLOGY Network Meta-Analysis PAIN MANAGEMENT Subfertility
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!